Skip to main content

Table 2 Primary and secondary endpoints

From: Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial

Primary endpoint

Change from baseline to 6 weeks for the HFSSS

Secondary endpoints

1. Change from baseline to 2, 4, 10, and 14 weeks for the HFSSS

2. Change from baseline to 2, 4, 6, 10, and 14 weeks for the frequency of hot flashes

3. Changes from baseline to 2, 4, 6, 10, and 14 weeks for the severity of hot flashes

4. The proportion of responders (at least a 50% reduction in the HFSSS) at 6, 10, and 14 weeks

5. Changes from baseline to 6, 10, and 14 weeks for the FACT-P

6. Changes from baseline to 6, 10, and 14 weeks for the IIEF-5

7. Changes from baseline to 6, 10, and 14 weeks for the SAS

8. Changes from baseline to 6, 10, and 14 weeks for the SDS